2012 Global Drugs of Abuse Testing Market Outlook: Growth Opportunities and Strategies
US$ 6,000.00
... a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others. "Drugs of Abuse Testing Market: US, Europe, Japan" is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging ...
April 2012
311 pages
2012 Global Immunoprotein Testing Market Outlook: Growth Opportunities and Strategies
US$ 6,000.00
During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and ... and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective ...
April 2012
297 pages
2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 22,800.00
... genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the ... identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the ...
April 2012
1200 pages
2012 Global Agrochemical Companies Product Portfolio Analyses
US$ 1,480.00
For each company, the analyses present: Extensive review of the major product lines. Applications, advantages and weaknesses of leading products. The companies analyzed in the report: Arysta, BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 75 pages.
April 2012
75 pages
2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 Germany Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
585 pages
2012 ItalyCancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
570 pages
2012 Japan Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 5,360.00
This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
April 2012
590 pages
2012 Spain Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
565 pages
2012 UK Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies
US$ 4,320.00
This report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...
April 2012
620 pages
The 2012 Leading Agrochemical Companies Financial Analyses
US$ 1,480.00
Each company’s analysis provides: Sales and operating profit by division, product line, and geographic region. Five-year sales and profit performance. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 85 pages and 65 tables
March 2012
85 pages
The 2012 Leading Agrochemical Companies R&D Expenditures and Major Programs
US$ 1,320.00
For each company, the report provides: Estimated R&D budget. Research facilities and staff. New technologies, products and applications in development. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 38 pages
March 2012
38 pages
The 2012 Leading Agrochemical Companies Collaborative Arrangements
US$ 1,200.00
... : Major joint ventures, distribution, OEM and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: BASF, Bayer, Dow, DuPont, Makhteshim-Agan, Monsanto, Nufarm, Sumitomo, and Syngenta. Contains 56 pages
March 2012
56 pages
The 2012 Top Ten World's Leading Chemical Companies
US$ 11,600.00
... include: To establish comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading chemical companies. To help current suppliers realistically assess their technological and marketing capabilities vis-a-vis leading competitors. To ...
March 2012
600 pages
The 2012 French Coagulation Market
US$ 4,320.00
... report presents a comprehensive analysis of the French coagulation market, including: Major issues pertaining to the French coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...
March 2012
405 pages
The 2012 German Coagulation Market
US$ 4,320.00
... report presents a comprehensive analysis of the German coagulation market, including: Major issues pertaining to the German coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...
March 2012
406 pages
The 2012 Italian Coagulation Market
US$ 4,320.00
... report presents a comprehensive analysis of the Italian coagulation market, including: Major issues pertaining to the Italian coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...
March 2012
402 pages
The 2012 Japanese Coagulation Market
US$ 5,200.00
This report presents a comprehensive analysis of the Japanese coagulation market, including: Major issues pertaining to the Japanese coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...
March 2012
402 pages
The 2012 Spanish Coagulation Market
US$ 4,320.00
... report presents a comprehensive analysis of the Spanish coagulation market, including: Major issues pertaining to the Spanish coagulation laboratory practice, as well as key ... with significant market impact during the next ten years. Ten-year volume and sales forecasts for 40 coagulation procedures performed ...
March 2012
398 pages
The 2012 UK Coagulation Market
US$ 4,320.00
This report presents a comprehensive analysis of the UK coagulation market, including: Major issues pertaining to the UK coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...
March 2012
409 pages
The 2012 US Coagulation Market
US$ 6,800.00
This report presents a comprehensive analysis of the US coagulation market, including: Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year ...
March 2012
424 pages
The 2012 Top Ten World's Leading Diagnostic Imaging Companies
US$ 10,000.00
... establish a comprehensive, factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world’s leading diagnostic imaging companies. To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis ...
March 2012
850 pages
The 2012 Leading Diagnostic Imaging Companies Strategic Directions
US$ 2,000.00
For each company, the report provides insightful strategic assessments, including: Business, new product development, and marketing strategies. Anticipated acquisitions, joint ventures, and divestitures. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu ...
March 2012
41 pages
The 2012 Leading Diagnostic Imaging Companies Marketing Tactics
US$ 2,000.00
For each company, the analysis presents: The U.S. and international sales force size in major geographic regions. Selling options, including rental plans, leasing and others. Promotional tactics, e.g., pricing, discounts, advertising, trade shows, seminars, product literature, newsletters, etc. System ...
March 2012
50 pages
The 2012 Leading Diagnostic Imaging Companies Comparative Analysis
US$ 680.00
This report ranks the world’s major diagnostic imaging companies according to the following criteria: Sales and market shares in the U.S., Europe, Japan and other geographic regions. Sales by modality. Operating profit and margins. R&D expenditures. The ...
March 2012
5 pages
The 2012 Leading Diagnostic Imaging Companies Collaborations
US$ 1,480.00
For each company, the report analyzes: Major joint venture, distribution, O.E.M., and licensing partners, both industrial and academic. Terms of collaborative agreements and specific products involved. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, ...
March 2012
82 pages
The 2012 Leading Diagnostic Imaging Companies Financial Analyses
US$ 1,960.00
Each company’s analysis provides: Sales estimates by division, geographic region, and modality. Five-year sales and operating profit performance. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, Hologic, Philips, Shimadzu, Siemens, and Toshiba. Contains 92 pages and 78 tables
March 2012
92 pages
The 2012 Leading Diagnostic Imaging Companies Organizations and Management
US$ 1,480.00
... and strategies. Recent acquisitions, divestitures, and significant organizational changes. Current organizational structure. Management philosophy and attitudes toward the diagnostic imaging market. Background of key executives. The companies analyzed in the report: Aloka, Analogic, Esaote, GE, Hitachi, ...
March 2012
92 pages
